Public Health Update: CDC Monitors Ebola Outbreak in DRC and Uganda

As of May 19, 2026, the Centers for Disease Control and Prevention (CDC) is actively responding to an outbreak of Ebola virus disease in the Democratic Republic of the Congo (DRC) and Uganda. The outbreak, which has been identified as the Bundibugyo virus subtype, has prompted international concern and a coordinated public health response.

Understanding the Current Situation

The World Health Organization has officially declared this outbreak a Public Health Emergency of International Concern (PHEIC). According to reports from the CDC, the virus has affected at least nine health zones in the DRC, with additional confirmed cases identified in Uganda among individuals who traveled from the affected region. This marks the 18th recorded Ebola outbreak in the DRC since the virus was first identified in 1976.

The CDC has activated its Emergency Response Center to support in-country efforts. Teams are currently focused on several critical areas:

• Surveillance and Contact Tracing: Identifying and monitoring individuals who may have been exposed.
• Laboratory Testing: Utilizing diagnostic capabilities to confirm cases rapidly.
• Infection Prevention and Control: Implementing clinical measures to prevent further transmission.
• Border Health Activities: Coordinating with local ministries to manage travel safety.

Risk Assessment for the American Public

For the general public in the United States, the CDC emphasizes that the risk remains low. Unlike respiratory viruses such as COVID-19, the Ebola virus is not transmitted through the air. Transmission typically occurs through direct contact with the blood or body fluids of an infected person who is symptomatic.

Dr. Satish K. Pillai, the CDC’s Ebola Response Incident Manager, noted that because the virus does not have an asymptomatic transmission phase, public health officials can effectively manage the threat through rigorous contact tracing, isolation, and supportive care. There are currently no FDA-approved vaccines or therapeutics specifically for the Bundibugyo virus subtype; early identification and supportive care remain the most effective strategies for improving patient outcomes.

Travel Guidance and Screening

The CDC continues to work closely with international partners to implement exit screening in both the DRC and Uganda. These measures are designed to identify individuals exhibiting symptoms before they travel. Travelers to these regions are advised to avoid contact with sick individuals and to monitor their health closely. Anyone who develops symptoms after travel to an area with an active outbreak should seek medical attention immediately and inform healthcare providers of their travel history.

Key Takeaways

• Virus Subtype: This outbreak is caused by the Bundibugyo virus.
• Transmission: Ebola is not airborne; individuals are typically only infectious when they are symptomatic.
• Response: The CDC is providing on-the-ground support in both the DRC and Uganda to assist with containment efforts.
• Travel: While exit screening is in place, travelers should exercise caution and report symptoms to local health authorities.

The situation remains dynamic. The CDC is actively assessing the needs on the ground and coordinating with interagency partners to manage the response. For the most current information regarding travel notices and health guidance, visit the official CDC website.